Back

Impact of per-procedural AF termination on recurrence after pulsed field ablation of persistent atrial fibrillation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Pulsed field ablation in persistent atrial fibrillation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sandrine Venier

CHU Grenoble, Grenoble (France)

6 More presentations in this session

Presentation thumbnail
Dual-energy versus PFA for catheter ablation treatment of patients with persistent atrial fibrillation: a systematic review and meta-analysis
Doctor O. Makdah (Cottbus, DE)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation of atrial fibrillation in patients with reduced ejection fraction: an international, multicenter study
Doctor L. Urbanek (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Contemporary pulsed field ablation workflows in Europe: real-world procedural strategies for paroxysmal and persistent atrial fibrillation in the FARAWAY registry
Doctor S. Tzeis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Personalized, algorithm-guided pulsed field ablation for persistent atrial fibrillation
Professor F. Anselme (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation cycle length dynamics during pulmonary vein isolation and posterior wall pulsed field ablation: predictive insights in patients with persistent atrial fibrillation
Doctor L. Bianchini (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulsed field ablation in persistent atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Pulsed field ablation for pulmonary vein isolation and additional lesion set in patients with persistent atrial fibrillation: safety, efficacy and long-term outcome from a nationwide experience
thumbnail
Congress Presentation
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience
thumbnail
Congress Presentation
Long-term outcomes of patients treated with pulsed field ablation under the first-in-human clinical trials with prospective invasive remap

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources